Estradiol and testosterone modulate the anesthetic action of the GABA-A agonist THIP, but not of the neurosteroid 3α,5β-pregnanolone in the rat

Author： González-Flores Oscar   Sánchez Norma   García-Juárez Marcos   Lima-Hernández Francisco   González-Mariscal Gabriela   Beyer Carlos  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.172, Iss.3, 2004-03, pp. : 283-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Structure and pharmacology of 4,5,6,7-tetrahydroisothiazolo[5,4-c]pyridin-3-ol (Thio-THIP), an agonist/antagonist at GABA A receptors

By Brehm L.   Ebert B.   Kristiansen U.   Wafford K.   Kemp J.   Krogsgaard-Larsen P.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 4, 1997-01 ,pp. : 357-363

Elsevier

Access to resources Recommend Favorite

An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze

By Collinson N.   Atack J.   Laughton P.   Dawson G.   Stephens D.  

Psychopharmacology, Vol. 188, Iss. 4, 2006-11 ,pp. : 619-628

Springer Publishing Company

Access to resources Recommend Favorite

Limited contribution of CYP3A5 to the hepatic 6β-hydroxylation of testosterone

By Kamdem Landry   Meineke Ingolf   Koch Ina   Zanger Ulrich   Brockmöller Jürgen   Wojnowski Leszek  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 1, 2004-07 ,pp. : 71-77

Springer Publishing Company

Access to resources Recommend Favorite

Dual action of the benzodiazepine receptor inverse agonist RU34347 on responses to exogenously applied GABA in the rat cerebellar slice - no reason for anxiety

By Pringle A.K.   Gardner C.R.   Walker R.J.  

General Pharmacology, Vol. 33, Iss. 2, 1999-08 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Action and Disposition of the β3-Agonist Nebivolol in the Presence of Inflammation; An Alternative to Conventional β1-Blockers

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1311-1317

Bentham Science Publishers

Access to resources Recommend Favorite